As filed with the Securities and Exchange Commission on May 14, 2020
No. 333-189402
No. 333-194781
No. 333-201242
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
Post-Effective
Amendment No. 1 to Form S-4 Registration Statement No. 333-189402
Post-Effective Amendment No. 1 to Form S-4 Registration Statement
No. 333-194781
Post-Effective Amendment No. 1 to Form S-4 Registration Statement No. 333-201242
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
Allergan plc
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Ireland
|
|
2834
|
|
98-1114402
|
(State or other Jurisdiction of
Incorporation or Organization)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification No.)
|
Clonshaugh Business and Technology Park
Coolock, Dublin, D17 E400, Ireland
+353 1 435 7700
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrants Principal Executive Offices)
Clonshaugh Business and Technology Park
Coolock, Dublin, D17 E400, Ireland
+353 1 435 7700
(Name,
Address and Telephone number, including area code, of Agent for Service)
With a
copy to:
Sophia Hudson, P.C.
Kirkland & Ellis LLP
601 Lexington Avenue
New York, New York 10022
(212) 446-4800
Approximate date of
commencement of proposed sale to the public: Not applicable. Removal from registration of securities that were not sold pursuant to the registration statement.
If the securities being registered on this Form are being offered in connection with the formation of a holding company and there is compliance with General
Instruction G, check the following box ☐
If this Form is filed to register additional securities for an offering pursuant to
Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, a smaller reporting company or an emerging growth company. See definitions of large accelerated filer, accelerated filer, small reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
Non-accelerated filer
|
|
☐
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
If applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction:
Exchange Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer) ☐
Exchange Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) ☐